Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Intercepting Pancreatic Cancer

Our Dream Team's Resolve to Stop Pancreatic Cancer

Goggins, Michael G., MD*†; Lippman, Scott M., MD; Constantinou, Pamela E., PhD§; Jacks, Tyler, PhD∥¶; Petersen, Gloria M., PhD#; Syngal, Sapna, MD, MPH**††; Maitra, Anirban, MBBS§‡‡

doi: 10.1097/MPA.0000000000001165
Editorials

From the *Department of Medicine (Gastroenterology), The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins Biostatistics Center;

Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD;

Division of Hematology/Oncology, Department of Medicine, Moores Center for Personalized Cancer Therapy, University of California, San Diego, La Jolla, CA;

§Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX;

David H. Koch Institute for Integrative Cancer Research;

Department of Biology, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA;

#Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN;

**Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School;

††Department of Medicine, Brigham & Women's Hospital, Boston, MA; and

‡‡Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Address correspondence to: Anirban Maitra, MBBS, Sheikh Ahmed Center for Pancreatic Cancer Research, Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit #1050, Houston, TX 77030 (e-mail: amaitra@mdanderson.org).

Michael Goggins, Scott M. Lippman, and Pamela E. Constantinou contributed equally to this work.

This research is supported by a Stand Up To Cancer (SU2C)–Lustgarten Foundation Pancreatic Cancer Interception Translational Cancer Research Grant (grant no. SU2C-AACR-DT25-17). SU2C is a program of the Entertainment Industry Foundation. Research grants are administered by the American Association for Cancer Research, the scientific partner of SU2C.

The authors declare no conflict of interest.

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.